The problem with KIT: clinical implications and practical difficulties with CD117 immunostaining.

Area of Science:

• Oncology
• Pathology
• Immunohistochemistry

Background:

• KIT (CD117) is a key marker for diagnosing gastrointestinal stromal tumors (GIST).
• KIT expression is also reported in various soft tissue tumors, potentially causing diagnostic confusion.
• Accurate KIT immunostaining is critical for GIST diagnosis and targeted therapy eligibility.

Purpose of the Study:

• To evaluate KIT (CD117) expression patterns in soft tissue sarcomas and GISTs.
• To assess the diagnostic implications of KIT staining in differentiating GIST from morphologically similar soft tissue sarcomas.
• To investigate discrepancies in reported KIT staining results in the literature.

Main Methods:

• Immunohistochemical staining for KIT (CD117) was performed.
• 144 soft tissue sarcoma cases and 11 GIST cases were analyzed.
• Staining patterns (diffuse global vs. focal) were characterized.

Main Results:

• Diffuse global KIT staining was characteristic of GIST.
• Synovial sarcoma and leiomyosarcoma showed KIT positivity, mimicking GIST.
• Focal KIT staining was observed in some cases, posing a diagnostic challenge, especially in biopsy material.
• Discrepancies in KIT staining results were noted compared to other studies, possibly due to antibody or protocol variations.

Conclusions:

• KIT (CD117) immunostaining is essential but can be challenging in soft tissue tumors.
• Morphological similarity and KIT expression in certain sarcomas necessitate careful diagnostic evaluation.
• Understanding KIT staining variability is critical for accurate GIST diagnosis and patient treatment decisions.